News
Mars travelers can use ‘Star Trek’ Tricorder-like features using smartphone biotech: study
Plans to take humans to the Moon and Mars come with numerous challenges, and the health of space travelers is no exception. One of the ways any ill-effects can be prevented or mitigated is by detecting relevant changes in the body and the body’s surroundings, something that biosensor technology is specifically designed to address on Earth. However, the small size and weight requirements for tech used in the limited habitats of astronauts has impeded its development to date.
A recent study of existing smartphone-based biosensors by scientists from Queen’s University Belfast (QUB) in the UK identified several candidates under current use or development that could be also used in a space or Martian environment. When combined, the technology could provide functionality reminiscent of the “Tricorder” devices used for medical assessments in the Star Trek television and movie franchises, providing on-site information about the health of human space travelers and biological risks present in their habitats.
Biosensors focus on studying biomarkers, i.e., the body’s response to environmental conditions. For example, changes in blood composition, elevations of certain molecules in urine, heart rate increases or decreases, and so forth, are all considered biomarkers. Health and fitness apps tracking general health biomarkers have become common in the marketplace with brands like FitBit leading the charge for overall wellness sensing by tracking sleep patterns, heart rate, and activity levels using wearable biosensors. Astronauts and other future space travelers could likely use this kind of tech for basic health monitoring, but there are other challenges that need to be addressed in a compact way.
The projected human health needs during spaceflight have been detailed by NASA on its Human Research Program website, more specifically so in its web-based Human Research Roadmap (HRR) where the agency has its scientific data published for public review. Several hazards of human spaceflight are identified, such as environmental and mental health concerns, and the QUB scientists used that information to organize their study. Their research produced a 20-page document reviewing the specific inner workings of the relevant devices found in their searches, complete with tables summarizing each device’s methods and suitability for use in space missions. Here are some of the highlights.

Risks in the Spacecraft Environment
During spaceflight, the environment is a closed system that has a two-fold effect: One, the immune system has been shown to decrease its functionality in long-duration missions, specifically by lowering white blood cell counts, and two, the weightless and non-competitive environment make it easier for microbes to transfer between humans and their growth rates increase. In one space shuttle era study, the number of microbial cells in the vehicle able to reproduce increased by 300% within 12 days of being in orbit. Also, certain herpes viruses, such as those responsible for chickenpox and mononucleosis, have been reactivated under microgravity, although the astronauts typically didn’t show symptoms despite the presence of active viral shedding (the virus had surfaced and was able to spread).
Frequent monitoring of the spacecraft environment and the crew’s biomarkers is the best way to mitigate these challenges, and NASA is addressing these issues to an extent with traditional instruments and equipment to collect data, although often times the data cannot be processed until the experiments are returned to Earth. An attempt has also been made to rapidly quantify microorganisms aboard the International Space Station (ISS) via a handheld device called the Lab-on-a-Chip Application Development-Portable Test System (LOCAD-PTS). However, this device cannot distinguish between microorganism species yet, meaning it can’t tell the difference between pathogens and harmless species. The QUB study found several existing smartphone-based technologies generally developed for use in remote medical care facilities that could achieve better identification results.

One of the devices described was a spectrometer (used to identify substances based on the light frequency emitted) which used the smartphone’s flashlight and camera to generate data that was at least as accurate as traditional instruments. Another was able to identify concentrations of an artificial growth hormone injected into cows called recominant bovine somatrotropin (rBST) in test samples, and other systems were able to accurately detect cyphilis and HIV as well as the zika, chikungunya, and dengue viruses. All of the devices used smartphone attachments, some of them with 3D-printed parts. Of course, the types of pathogens detected are not likely to be common in a closed space habitat, but the technology driving them could be modified to meet specific detection needs.
The Stress of Spaceflight
A group of people crammed together in a small space for long periods of time will be impacted by the situation despite any amount of careful selection or training due to the isolation and confinement. Declines in mood, cognition, morale, or interpersonal interaction can impact team functioning or transition into a sleep disorder. On Earth, these stress responses may seem common, or perhaps an expected part of being human, but missions in deep space and on Mars will be demanding and need fully alert, well-communicating teams to succeed. NASA already uses devices to monitor these risks while also addressing the stress factor by managing habitat lighting, crew movement and sleep amounts, and recommending astronauts keep journals to vent as needed. However, an all-encompassing tool may be needed for longer-duration space travels.
As recognized by the QUB study, several “mindfulness” and self-help apps already exist in the market and could be utilized to address the stress factor in future astronauts when combined with general health monitors. For example, the popular FitBit app and similar products collect data on sleep patterns, activity levels, and heart rates which could potentially be linked to other mental health apps that could recommend self-help programs using algorithms. The more recent “BeWell” app monitors physical activity, sleep patterns, and social interactions to analyze stress levels and recommend self-help treatments. Other apps use voice patterns and general phone communication data to assess stress levels such as “StressSense” and “MoodSense”.

Advances in smartphone technology such as high resolution cameras, microphones, fast processing speed, wireless connectivity, and the ability to attach external devices provide tools that can be used for an expanding number of “portable lab” type functionalities. Unfortunately, though, despite the possibilities that these biosensors could mean for human spaceflight needs, there are notable limitations that would need to be overcome in some of the devices. In particular, any device utilizing antibodies or enzymes in its testing would risk the stability of its instruments thanks to radiation from galactic cosmic rays and solar particle events. Biosensor electronics might also be damaged by these things as well. Development of new types of shielding may be necessary to ensure their functionality outside of Earth and Earth orbit or, alternatively, synthetic biology could also be a source of testing elements genetically engineered to withstand the space and Martian environments.
The interest in smartphone-based solutions for space travelers has been garnering more attention over the years as tech-centric societies have moved in the “app” direction overall. NASA itself has hosted a “Space Apps Challenge” for the last 8 years, drawing thousands of participants to submit programs that interpret and visualize data for greater understanding of designated space and science topics. Some of the challenges could be directly relevant to the biosensor field. For example, in the 2018 event, contestants are asked to develop a sensor to be used by humans on Mars to observe and measure variables in their environments; in 2017, contestants created visualizations of potential radiation exposure during polar or near-polar flight.
While the QUB study implied that the combination of existing biosensor technology could be equivalent to a Tricorder, the direct development of such a device has been the subject of its own specific challenge. In 2012, the Qualcomm Tricorder XPRIZE competition was launched, asking competitors to develop a user-friendly device that could accurately diagnose 13 health conditions and capture 5 real-time health vital signs. The winner of the prize awarded in 2017 was Pennsylvania-based family team called Final Frontier Medical Devices, now Basil Leaf Technologies, for their DxtER device. According to their website, the sensors inside DxtER can be used independently, one of which is in a Phase 1 Clinical Trial. The second place winner of the competition used a smartphone app to connect its health testing modules and generate a diagnosis from the data acquired from the user.
The march continues to develop the technology humans will need to safely explore regions beyond Earth orbit. Space is hard, but it was hard before we went there the first time, and it was hard before we put humans on the moon. There may be plenty of challenges to overcome, but as the Queen’s University Belfast study demonstrates, we may already be solving them. It’s just a matter of realizing it and expanding on it.
Investor's Corner
SpaceX and Nvidia team up on Musk’s orbital AI bet
SpaceX revealed a new Nvidia satellite partnership, then Musk pledged an exclusive Nvidia hardware commitment.
SpaceX and Nvidia are now working together on the hardware that will power Musk’s orbital data center ambitions. SpaceX announced on X on Tuesday that it is partnering with Nvidia to design the compute payload for Starmind AI1, the first satellite in a planned constellation built to run AI workloads directly in orbit. Each Starmind satellite will carry Nvidia’s Rubin GPUs and Vera CPUs, according to the post, which included renderings of the payload design.
The announcement landed hours before SpaceX’s first earnings call as a public company, where Musk went further, saying the company has committed to building its AI infrastructure exclusively on Nvidia hardware. “We think the Vera Rubin architecture is the best architecture. We think it’s the best AI computer, and we greatly value our close cooperation and partnership on many levels with Nvidia,” Musk told investors on the call,. “So we’re exclusive to Nvidia.”
Musk said SpaceX plans to deploy Nvidia’s Vera Rubin NVL72 rackscale system, codenamed Kyber, both on the ground and in space. He set a target of 2 gigawatts of compute capacity online by the end of this year, scaling to roughly 10 gigawatts by the end of 2027.
SpaceX’s newest Starmind will make earth data centers obsolete
Starmind has been in development since Musk confirmed the name in June, following an xAI trademark filing that tipped off the project before SpaceX made it official. The idea is massive in scope and instead of moving data down to ground based servers, satellites equipped with onboard processors and large solar arrays would compute AI workloads in orbit and beam results back to Earth. SpaceX has already filed with the FCC for a constellation of up to one million satellites to support the effort, citing constant solar power and the absence of zoning restrictions as advantages over terrestrial data centers.
The Nvidia exclusivity marks a shift in tone from just two weeks ago, when Musk was busy knocking down a report that SpaceX had ordered $52 billion worth of Nvidia GPUs through Foxconn, calling it fake news at the time. The dollar figure in that rumor may have been wrong, but the underlying direction seems correct. SpaceX’s AI division already leases Colossus compute capacity to Anthropic and Google, and Tuesday’s earnings report showed AI revenue climbing sharply as those deals ramp up.
Nvidia shares rose roughly 3% in Tuesday trading on the news, while SpaceX stock climbed nearly 9% during the day before giving back gains after hours as investors digested the earnings report’s capital spending figures.
Investor's Corner
SpaceX reports beat in first earnings while minimizing losses
SpaceX (NASDAQ: SPCX) reported a beat in revenues and EBITDA in its first earnings call report while also minimizing losses as its business continues to gain momentum.
After its IPO in July, SpaceX saw some tough losses on Wall Street due to a major selloff after a delay in its 13th Starship test flight. The ship launched later that week and completed what was arguably the most successful IFT operation in the Starship program’s history.
Nevertheless, the company is continuing on and reported some encouraging financials while also promoting what appears to be a robust outlook moving forward in its Space, AI, and Connectivity divisions.
SpaceX to report first-ever earnings today: here’s what to expect
Earnings Results
- Revenues: $7.8 billion reported vs. $6.7 billion expected
- Adjusted EBITDA: $3.5 billion vs. $2 billion expected
- Net loss of $541 million, an improvement of $467 million from net loss of $1.0 billion
Additionally, CFO Bret Johnsen had these comments:
“2026 has been a momentous year so far, and the second quarter demonstrated the true power of SpaceX. Revenue growth accelerated across all our business segments and we delivered strong operating leverage, with significant margin expansion led by our new AI compute agreements. Our unparalleled leadership in launch, Starlink subscriber growth, new enterprise and government partnerships, and best-in-class AI infrastructure underscore our ability to drive meaningful scale and deliver attractive returns. As a newly public company, we are delighted to welcome our broad base of shareholders and bondholders. We ended the second quarter with $100 billion of cash, cash equivalents, and marketable securities, and $47.5 billion in backlog. This financial strength gives us substantial capacity to invest in Starship, Starlink Broadband and Mobile satellites, and our AI platform, while maintaining a disciplined long-term capital allocation framework.”
Space Business Highlights
SpaceX shared some of its biggest Space Business Highlights for Q2:
- Space revenues grew 55% sequentially and 29% year-over-year to $962 million, driven by a higher number of large customer launches and a favorable customer shift compared to the prior year
- Total costs and expenses for the Space segment were up by $389 million year-over-year, as we continued to accelerate R&D investments in our Starship program, which we believe will reduce the cost to orbit by 99% or more relative to the historical average, and unlock significant revenue potential across all business segments
- Leading launch provider for the world with 78 launches and 1,041 metric tons of mass to orbit deployed over the six months ended June 30, 2026, primarily allocated to Connectivity for the deployment of our Starlink constellation
- Starship V3 development continued to advance towards full and rapid reusability:
- Completed Starship V3’s first suborbital mission in May, Flight 12, which achieved a successful lift off from our new Starbase pad, a precision landing of Starship’s upper stage, and deployment of modified V2 Starlink satellites
- Subsequent to the second quarter, completed Starship Flight 13 in July, which achieved all flight objectives including deploying 20 production V3 satellites, demonstrating in-space relight of a Raptor engine, and executing the softest ever splashdown of Starship, providing critical views of an intact heatshield
SpaceX will report its earnings today at 4:30 P.M. EDT.
Elon Musk
Elon Musk sends second warning to SpaceX shorts ahead of first earnings
Elon Musk issued a second pointed warning to SpaceX short sellers on Tuesday, just hours before the company was set to release its first quarterly earnings as a publicly traded firm. Responding to a report highlighting elevated short interest, Musk wrote on X: “I try to warn them, but they just double down …”
The comment came as data from S3 Partners showed roughly 95 percent of available SPCX shares to borrow were on loan, translating to about 34 percent short interest as a percentage of the float. The stock has traded under pressure since its record-breaking IPO in June 2026, declining significantly from early peaks.
I try to warn them, but they just double down … 🤷♂️
— Elon Musk (@elonmusk) August 4, 2026
This marks the second such message from Musk in under three weeks.
On July 17, amid post-IPO volatility, he stated: “The survival probability of firms who maintain a significant short position in SpaceX over time is very low.” At that time, SPCX had fallen roughly 30 percent from its peak above a $2.6 trillion valuation, with short sellers reportedly realizing gains of about $8.7 billion.
Musk’s warning aligned with optimistic analyses projecting that Starship-driven cost reductions could enable a multi-trillion-dollar space economy through applications such as orbital solar power, asteroid mining, data centers, and Mars-related projects, positioning SpaceX as critical infrastructure.
SpaceX is scheduled to report second-quarter results after the market close later today, followed by a webcast. Analysts anticipate revenue near $6.9 billion, reflecting growth in Starlink, launch services, and AI-related segments. The earnings release precedes a major lockup expiration on August 6 that could free hundreds of millions of insider shares.
Musk has a long track record of confronting short sellers, particularly regarding Tesla, where he has argued that persistent bearish positions underestimate transformative technologies. Critics view his optimism as overly ambitious given near-term stock fluctuations, while supporters see temporary dips as opportunities in a longer-term expansion of the space economy.
As SpaceX opens its books to public scrutiny for the first time, the high short interest and Musk’s repeated cautions set the stage for heightened market attention on the results and management’s commentary.

